Voyager Therapeutics (VYGR) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to -$30.1 million.
- Voyager Therapeutics' Other Gross PP&E Adjustments rose 1520.43% to -$30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.1 million, marking a year-over-year increase of 1520.43%. This contributed to the annual value of -$4.0 million for FY2024, which is 13147.3% down from last year.
- Latest data reveals that Voyager Therapeutics reported Other Gross PP&E Adjustments of -$30.1 million as of Q3 2025, which was up 1520.43% from -$31.7 million recorded in Q2 2025.
- Voyager Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $14.9 million during Q4 2022, with a 5-year trough of -$39.8 million in Q1 2024.
- In the last 5 years, Voyager Therapeutics' Other Gross PP&E Adjustments had a median value of -$30.1 million in 2025 and averaged -$21.3 million.
- As far as peak fluctuations go, Voyager Therapeutics' Other Gross PP&E Adjustments skyrocketed by 53851.57% in 2022, and later crashed by 15022.95% in 2024.
- Over the past 5 years, Voyager Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$3.4 million in 2021, then soared by 538.52% to $14.9 million in 2022, then dropped by 13.94% to $12.9 million in 2023, then tumbled by 131.47% to -$4.0 million in 2024, then plummeted by 644.21% to -$30.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$30.1 million for Q3 2025, versus -$31.7 million for Q2 2025 and -$32.9 million for Q1 2025.